NPIL-DRL spat over anti-cancer drug relapses
The spat between Nicholas Piramal India Ltd (NPIL) and Dr Reddy's Laboratories over the latter's indigenous anti-cancer biotech drug G-CSF (grastim) has taken a new twist, with NPIL asking the health
The spat between Nicholas Piramal India Ltd (NPIL) and Dr Reddy's Laboratories over the latter's indigenous anti-cancer biotech drug G-CSF (grastim) has taken a new twist, with NPIL asking the health